RDY 226 Pill: white, capsule/oblong, 13mm
The pill with imprint RDY 226 (White, Capsule/Oblong, 13mm) has been identified as Lamotrigine (Chewable, Dispersible) 25 mg and is used for Bipolar Disorder, Lennox-Gastaut Syndrome, Seizure Prevention, Epilepsy, and Seizures. It belongs to the drug class triazine anticonvulsants and is not a controlled substance.
Images for RDY 226
Lamotrigine (Chewable, Dispersible)
- Imprint
- RDY 226
- Strength
- 25 mg
- Color
- White
- Size
- 13.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC)
- 55111-0226
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
magnesium stearate,
mannitol,
microcrystalline cellulose,
corn starch,
saccharin sodium,
magnesium silicate,
black currant
Note: Inactive ingredients may vary.
See also:
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,849)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
- Lamotrigine Tablets (FDA)
- Lamotrigine, tablets for suspension (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.